Cargando…

Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori

Helicobacter pylori antibiotic resistance is increasing worldwide, emphasizing the urgent need for more rapid resistance detection prior to the administration of H. pylori eradication regimens. Macrolides and fluoroquinolones are widely used to treat H. pylori. In this study, we aimed to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Egli, Konrad, Wagner, Karoline, Keller, Peter M, Risch, Lorenz, Risch, Martin, Bodmer, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773895/
https://www.ncbi.nlm.nih.gov/pubmed/33392106
http://dx.doi.org/10.3389/fcimb.2020.596371
_version_ 1783630147126034432
author Egli, Konrad
Wagner, Karoline
Keller, Peter M
Risch, Lorenz
Risch, Martin
Bodmer, Thomas
author_facet Egli, Konrad
Wagner, Karoline
Keller, Peter M
Risch, Lorenz
Risch, Martin
Bodmer, Thomas
author_sort Egli, Konrad
collection PubMed
description Helicobacter pylori antibiotic resistance is increasing worldwide, emphasizing the urgent need for more rapid resistance detection prior to the administration of H. pylori eradication regimens. Macrolides and fluoroquinolones are widely used to treat H. pylori. In this study, we aimed to compare the diagnostic performance of A) 23SrDNA qPCR (with melting curve analysis) and an in-house developed gyrA qPCR followed by Sanger sequencing with a commercial IVD-marked hybridization probe assay (for 23SrDNA and gyrA) using 142 gastric biopsies (skipping culturing) and B) the same two qPCR for 23SrDNA and gyrA (including Sanger sequencing) with whole-genome sequencing (WGS) and phenotypic characterization of clarithromycin and levofloxacin resistance using 76 cultured isolates. The sensitivity of both qPCRs was 100% compared to that of the commercial IVD-marked hybridization probe assay for the detection of H. pylori in gastric biopsies (without resistance testing). The specificity of the qPCR gyrA followed by Sanger sequencing was 100%, indicating that the best sequence identity was always H. pylori. The results show good agreement between molecular tests, especially between qPCR (inclusive Sanger sequencing) and WGS. Discrepancies (concerning mutated or wild type of positive H. pylori gastric biopsies) were observed between Sanger sequencing of the gyrA gene and the corresponding commercial hybridization probe assay, mostly because the high sequence diversity of the gyrA gene even at positions adjacent to the relevant codons of 87 and 91 interfered with obtaining correct results from the hybridization probe assay. Interestingly, we found several mixed sequences, indicating mixed populations in the gastric biopsies (direct detection without culturing). There was a high percentage of both levofloxacin and clarithromycin resistance in gastric biopsies (both between 22% and 29%, direct detection in gastric biopsies). Therefore, we recommend analyzing both targets in parallel. We confirmed that phenotypic resistance is highly correlated with the associated mutations. We concluded that the two qPCR followed by Sanger sequencing of the gyrA gene is a fast, cost-effective and comprehensive method for resistance testing of H. pylori directly in gastric biopsies.
format Online
Article
Text
id pubmed-7773895
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77738952021-01-01 Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Egli, Konrad Wagner, Karoline Keller, Peter M Risch, Lorenz Risch, Martin Bodmer, Thomas Front Cell Infect Microbiol Cellular and Infection Microbiology Helicobacter pylori antibiotic resistance is increasing worldwide, emphasizing the urgent need for more rapid resistance detection prior to the administration of H. pylori eradication regimens. Macrolides and fluoroquinolones are widely used to treat H. pylori. In this study, we aimed to compare the diagnostic performance of A) 23SrDNA qPCR (with melting curve analysis) and an in-house developed gyrA qPCR followed by Sanger sequencing with a commercial IVD-marked hybridization probe assay (for 23SrDNA and gyrA) using 142 gastric biopsies (skipping culturing) and B) the same two qPCR for 23SrDNA and gyrA (including Sanger sequencing) with whole-genome sequencing (WGS) and phenotypic characterization of clarithromycin and levofloxacin resistance using 76 cultured isolates. The sensitivity of both qPCRs was 100% compared to that of the commercial IVD-marked hybridization probe assay for the detection of H. pylori in gastric biopsies (without resistance testing). The specificity of the qPCR gyrA followed by Sanger sequencing was 100%, indicating that the best sequence identity was always H. pylori. The results show good agreement between molecular tests, especially between qPCR (inclusive Sanger sequencing) and WGS. Discrepancies (concerning mutated or wild type of positive H. pylori gastric biopsies) were observed between Sanger sequencing of the gyrA gene and the corresponding commercial hybridization probe assay, mostly because the high sequence diversity of the gyrA gene even at positions adjacent to the relevant codons of 87 and 91 interfered with obtaining correct results from the hybridization probe assay. Interestingly, we found several mixed sequences, indicating mixed populations in the gastric biopsies (direct detection without culturing). There was a high percentage of both levofloxacin and clarithromycin resistance in gastric biopsies (both between 22% and 29%, direct detection in gastric biopsies). Therefore, we recommend analyzing both targets in parallel. We confirmed that phenotypic resistance is highly correlated with the associated mutations. We concluded that the two qPCR followed by Sanger sequencing of the gyrA gene is a fast, cost-effective and comprehensive method for resistance testing of H. pylori directly in gastric biopsies. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773895/ /pubmed/33392106 http://dx.doi.org/10.3389/fcimb.2020.596371 Text en Copyright © 2020 Egli, Wagner, Keller, Risch, Risch and Bodmer http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Egli, Konrad
Wagner, Karoline
Keller, Peter M
Risch, Lorenz
Risch, Martin
Bodmer, Thomas
Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title_full Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title_fullStr Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title_full_unstemmed Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title_short Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
title_sort comparison of the diagnostic performance of qpcr, sanger sequencing, and whole-genome sequencing in determining clarithromycin and levofloxacin resistance in helicobacter pylori
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773895/
https://www.ncbi.nlm.nih.gov/pubmed/33392106
http://dx.doi.org/10.3389/fcimb.2020.596371
work_keys_str_mv AT eglikonrad comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori
AT wagnerkaroline comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori
AT kellerpeterm comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori
AT rischlorenz comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori
AT rischmartin comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori
AT bodmerthomas comparisonofthediagnosticperformanceofqpcrsangersequencingandwholegenomesequencingindeterminingclarithromycinandlevofloxacinresistanceinhelicobacterpylori